Status:
RECRUITING
Steroid Diabetes in Patients With Kidney Disease
Lead Sponsor:
Zhejiang Provincial People's Hospital
Collaborating Sponsors:
The Third Affiliated Hospital of Wenzhou Medical University
The First People's Hospital of Xiaoshan District, Hangzhou City
Conditions:
Nephrotic Syndrome
Eligibility:
All Genders
18-75 years
Brief Summary
If steroid diabetes is not recognized in time, it will cause irreversible damage to the body. Nephropathy patients are more likely to have steroid diabetes ,the incidence rate up to 25%,due to hypoalb...
Detailed Description
1. Patients with nephrosis who had taken glucocorticoid for the first time were followed up, and those who had diabetes themselves were excluded. 2. Regularly follow up and record information on gluco...
Eligibility Criteria
Inclusion
- Patients who need to use glucocorticoids due to the following diseases: nephrotic syndrome, Immunoglobulin A nephropathy, membranous nephropathy, Anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV), systemic lupus erythematosus；
- Initial daily dose of glucocorticoids greater than or equal to 10mg of prednisolone；
Exclusion
- Patients with diabetes；
- Those who are unable to communicate through language；
- Uremic patients；
- Unable to perform blood glucose monitoring and follow-up as required；
- Those who have used glucocorticoids within the past 3 months and have accumulated a dose of 10mg or more of prednisone；
- Participated in other clinical studies。
Key Trial Info
Start Date :
January 10 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 28 2027
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06161701
Start Date
January 10 2024
End Date
February 28 2027
Last Update
April 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhejiang provincial people's hospital
Hangzhou, Zhejiang, China, 0571